Telerehabilitation Compared With Clinic-Based Physiotherapy in Children With Spastic Cerebral Palsy
Effectiveness of Structured Telerehabilitation Compared With Clinic-Based Physiotherapy for Improving Gross Motor Functions in Young Children With Spastic Cerebral Palsy
This randomized controlled trial will compare structured telerehabilitation with clinic-based physiotherapy in children aged 4-12 years with spastic cerebral palsy. Both groups will receive physiotherapy three times per week for 12 weeks. The study will evaluate changes in gross motor function using the Gross Motor Function Measure (GMFM-88), assess spasticity using the Modified Ashworth Scale (MAS), and examine the usability of telerehabilitation using the Telehealth Usability Questionnaire (TUQ). The study aims to determine whether structured telerehabilitation can provide an effective alternative to clinic-based physiotherapy while potentially reducing barriers related to travel, cost, and access to pediatric rehabilitation services.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The primary objective of this randomized controlled trial is to compare the effectiveness of structured telerehabilitation and clinic-based physiotherapy in improving gross motor functions among children aged 4-12 years with spastic cerebral palsy classified at Gross Motor Function Classification System (GMFCS) levels I-III. A secondary objective is to assess the usability of structured telerehabilitation using the Telehealth Usability Questionnaire (TUQ). A total of 44 participants will be randomly allocated to two groups, with 22 participants in each group. Both groups will receive physiotherapy three times per week for 12 weeks, with each session lasting approximately 45 minutes. Gross motor function will be assessed using the Gross Motor Function Measure-88 (GMFM-88), while spasticity will be evaluated using the Modified Ashworth Scale (MAS). Assessments will be conducted at baseline, six weeks, and 12 weeks to monitor changes during the intervention period. The study will determine whether structured telerehabilitation can provide comparable improvements in gross motor function to clinic-based physiotherapy and evaluate its usability as an alternative approach to delivering pediatric rehabilitation services.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Zahoor Dr. Zahoor Ahmed, Phd
- Numéro de téléphone: +92 315 6767569
- E-mail: Zahoor_riphah@hotmail.com
Lieux d'étude
-
-
Kpk
-
Swābi, Kpk, Pakistan, 23430
- Recrutement
- Health and wellness physiotherapy and rehabilitation centre shewa adda swabi
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Children aged 4-12 years diagnosed with spastic cerebral palsy.
- Children classified at Gross Motor Function Classification System (GMFCS) levels I-III.
- Medically stable children able to participate in physiotherapy sessions.
- Availability of caregiver support and internet access sufficient to participate in telerehabilitation sessions.
- Written informed consent provided by a parent or legal guardian.
Exclusion Criteria:
- Children without adequate internet access or caregiver support required for telerehabilitation.
- Children with uncontrolled seizures or severe comorbidities that interfere with safe participation in physiotherapy.
- Children classified at GMFCS levels IV-V.
- Children who have undergone orthopedic surgery or received botulinum toxin injections within the preceding 6 months.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Structured Telerehabilitation
Participants will receive a structured physiotherapy program remotely through video communication, three times per week for 12 weeks, with approximately 45 minutes per session. |
A structured physiotherapy program delivered remotely through video communication under physiotherapist guidance, with caregiver assistance. The program will be conducted three times per week for 12 weeks, with each session lasting approximately 45 minutes. Exercises will include stretching, range-of-motion exercises, strengthening, balance training, functional mobility, postural control, and coordination activities tailored to the child's functional abilities. |
|
Comparateur actif: Clinic-Based Physiotherapy
Participants will receive a structured physiotherapy program in a clinical setting under direct physiotherapist supervision, three times per week for 12 weeks, with approximately 45 minutes per session. |
A structured physiotherapy program delivered in a clinical setting under direct physiotherapist supervision. The program will be conducted three times per week for 12 weeks, with each session lasting approximately 45 minutes. Exercises will include stretching, range-of-motion exercises, strengthening, balance training, functional mobility, postural control, and coordination activities tailored to the child's functional abilities. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Gross Motor Function Measure-88 (GMFM-88) Score
Délai: Baseline, 6 weeks, and 12 weeks after the start of the intervention.
|
Gross motor function will be assessed using the Gross Motor Function Measure-88 (GMFM-88), a standardized tool used to evaluate motor abilities in children with cerebral palsy across five dimensions: lying and rolling, sitting, crawling and kneeling, standing, and walking, running, and jumping. Changes in GMFM-88 scores from baseline to the end of the 12-week intervention will be compared between the structured telerehabilitation and clinic-based physiotherapy groups. |
Baseline, 6 weeks, and 12 weeks after the start of the intervention.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Modified Ashworth Scale (MAS) Scores
Délai: Baseline and 12 weeks after the start of the intervention.
|
Spasticity will be assessed using the Modified Ashworth Scale (MAS), which measures resistance to passive movement during clinical examination. Changes in MAS scores from baseline to the end of the intervention will be compared between the two study groups. |
Baseline and 12 weeks after the start of the intervention.
|
|
Usability of the Structured Telerehabilitation Program
Délai: At the end of the 12-week intervention.
|
The usability of the structured telerehabilitation program will be assessed using the Telehealth Usability Questionnaire (TUQ) at the end of the intervention. The questionnaire will evaluate caregivers' perceptions of the usability and acceptability of the telerehabilitation approach. |
At the end of the 12-week intervention.
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Zobia Naeem, MS, Riphah International University
Publications et liens utiles
Publications générales
- Novak I, Morgan C, Fahey M, Finch-Edmondson M, Galea C, Hines A, Langdon K, Namara MM, Paton MC, Popat H, Shore B, Khamis A, Stanton E, Finemore OP, Tricks A, Te Velde A, Dark L, Morton N, Badawi N. State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy. Curr Neurol Neurosci Rep. 2020 Feb 21;20(2):3. doi: 10.1007/s11910-020-1022-z.
- Morgan C, Fetters L, Adde L, Badawi N, Bancale A, Boyd RN, Chorna O, Cioni G, Damiano DL, Darrah J, de Vries LS, Dusing S, Einspieler C, Eliasson AC, Ferriero D, Fehlings D, Forssberg H, Gordon AM, Greaves S, Guzzetta A, Hadders-Algra M, Harbourne R, Karlsson P, Krumlinde-Sundholm L, Latal B, Loughran-Fowlds A, Mak C, Maitre N, McIntyre S, Mei C, Morgan A, Kakooza-Mwesige A, Romeo DM, Sanchez K, Spittle A, Shepherd R, Thornton M, Valentine J, Ward R, Whittingham K, Zamany A, Novak I. Early Intervention for Children Aged 0 to 2 Years With or at High Risk of Cerebral Palsy: International Clinical Practice Guideline Based on Systematic Reviews. JAMA Pediatr. 2021 Aug 1;175(8):846-858. doi: 10.1001/jamapediatrics.2021.0878.
- Novak I, Morgan C, Adde L, Blackman J, Boyd RN, Brunstrom-Hernandez J, Cioni G, Damiano D, Darrah J, Eliasson AC, de Vries LS, Einspieler C, Fahey M, Fehlings D, Ferriero DM, Fetters L, Fiori S, Forssberg H, Gordon AM, Greaves S, Guzzetta A, Hadders-Algra M, Harbourne R, Kakooza-Mwesige A, Karlsson P, Krumlinde-Sundholm L, Latal B, Loughran-Fowlds A, Maitre N, McIntyre S, Noritz G, Pennington L, Romeo DM, Shepherd R, Spittle AJ, Thornton M, Valentine J, Walker K, White R, Badawi N. Early, Accurate Diagnosis and Early Intervention in Cerebral Palsy: Advances in Diagnosis and Treatment. JAMA Pediatr. 2017 Sep 1;171(9):897-907. doi: 10.1001/jamapediatrics.2017.1689.
- İlhanlı M, İlhanlı İ, Çelenk P. Cerebral palsy and oral health. Deneysel ve Klinik Tıp Dergisi. 2022;39(4):1283-93.
- Gong C, Liu X, Fang L, Liu A, Lian B, Qi X, Chen S, Li H, Zhao M, Guo J, Zhou S. Prevalence of cerebral palsy comorbidities in China: a systematic review and meta-analysis. Front Neurol. 2023 Sep 28;14:1233700. doi: 10.3389/fneur.2023.1233700. eCollection 2023.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- Adan Nisar
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .